Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone vs Bevacizumab for Diabetic Macular Edema
NCT00874744Phase 2Completed
- Sponsor
- Universidade Federal de Goiás
- Start
- Mar 2008
- Primary completion
- Sep 2008
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
01
Overview
A Phase 2 trial of bevacizumab, triamcinolone acetonide in diabetic macular edema (DME), sponsored by Universidade Federal de Goiás. Started Mar 2008; status: completed.
02
Drugs
bevacizumabtriamcinolone acetonide
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00874744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00874744.